<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-WDWZDMYS/104d789a-df35-43ea-8cbc-710e13626ba6/PDF"><dcterms:extent>163 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-WDWZDMYS/e2348810-2445-4e2a-a414-269debf548cb/TEXT"><dcterms:extent>54 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-WDWZDMYS"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2005</dcterms:issued><dc:creator>Novljan, Gregor</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:44</dc:format><dc:format xml:lang="sl">str. 339-354</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:20583897</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-WDWZDMYS</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">Age Factors</dc:subject><dc:subject xml:lang="en">Child</dc:subject><dc:subject xml:lang="en">Child Development</dc:subject><dc:subject xml:lang="en">Graft Survival</dc:subject><dc:subject xml:lang="en">Immunosuppressive Agents</dc:subject><dc:subject xml:lang="sl">Imunosupresivi</dc:subject><dc:subject xml:lang="en">Kidney Failure, Chronic</dc:subject><dc:subject xml:lang="en">Kidney Transplantation</dc:subject><dc:subject xml:lang="sl">kronična ledvična odpoved</dc:subject><dc:subject xml:lang="sl">Ledvica, odpoved kronična</dc:subject><dc:subject xml:lang="sl">Ledvica, presaditev</dc:subject><dc:subject xml:lang="sl">ledvične bolezni</dc:subject><dc:subject xml:lang="sl">otroci</dc:subject><dc:subject xml:lang="sl">Otrok</dc:subject><dc:subject xml:lang="sl">Otrok, razvoj</dc:subject><dc:subject xml:lang="sl">presajanje organov</dc:subject><dc:subject xml:lang="sl">Preživetje, analiza</dc:subject><dc:subject xml:lang="en">Prognosis</dc:subject><dc:subject xml:lang="sl">Prognoza</dc:subject><dc:subject xml:lang="sl">Starostni faktorji</dc:subject><dc:subject xml:lang="en">Survival Analysis</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">Vsadek, preživetje</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q7569" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Presaditev ledvice kot sodobno zdravljenje otrok s končno ledvično odpovedjo| Kidney transplantation as modern treatment for children with terminal renal failure|</dc:title><dc:description xml:lang="sl">The number of children treated for terminal renal failure (TRF) has increased over the last decade. In spite of this, the incidence of newly discovered children and adolescents with CKD is much lower than in adults. In the past years, the results of kidney transplantation in children have been improving and are approaching those in adults. Improvement in transplantation results isa consequence of better knowledge of the factors affecting graft survival and progress in the field of immunosuppressive treatment. Kidney transplantation is now the method of choice for the treatment of children withCKD. As part of immunosuppressive treatment in recent years, induction treatment of children with antibodies is growing increasingly more popular. Research in the field of immunosuppressive treatment is focused primarily on replacing medications with significant adverse effects (steroids, cyclosporin). Patient noncompliance in taking the prescribed medicines is among important reasons for chronic transplant rejection, which is the most common reason for poor transplantation results in children and adolescents. Fear of cosmetic side effects of immunosuppressive treatment has a significanteffect on patient compliance and is most pronounced in adolescent girls. Care for appropriate growth is one of priority tasks in the management of children and adolescents with terminal renal failure. New steroid-free immunosuppressive protocols could improve growth after renal transplantation. Modern immunosuppressive treatment has significantly reduced the number of acute rejection reactions. At the same time, the number of viral and bacterialinfections following transplantation has increased. Infections are the most commonly stated causes of death in children with transplanted kidneys. (Abstract truncated at 2000 characters)</dc:description><dc:description xml:lang="sl">Število otrok, zdravljenih zaradi končne ledvične odpovedi (KLO), se v zadnjemdesetletju povečuje. Kljub temu je pojavnost novo odkritih otrok in mladostnikov s KLO izrazito manjša kot pri odraslih. V zadnjih letih se rezultati presaditve ledvice pri otrocih izboljšujejo in približujejo tistim pri odraslih. Izboljšanje rezultatov presaditve je posledica boljšega poznavanja dejavnikov, ki vplivajo na preživetje presadka in napredka na področju imunosupresivnega zdravljenja. Presaditev ledvice je danes izborni način zdravljenja otrok s KLO. V sklopu imunosupresivnega zdravljenja je v zadnjih letih tudi pri otrocih vse bolj priljubljeno indukcijsko zdravljenje sprotitelesi. Raziskave na področju imunosupresivnega zdravljenja so usmerjenepredvsem v nadomeščanje zdravil s pomembnimi stranskimi učinki (steroidi, ciklosporin). Nesodelovanje bolnikov pri jemanju predpisanih zdravil je eden od pomembnih razlogov za kronično zavrnitev presadka, kar je najpogostejši razlog za slab uspeh presaditve pri otrocih in mladostnikih. Strah pred kozmetičnimi stranskimi učinki imunosupresivnega zdravljenja pomembno vpliva na sodelovanje in je še najbolj izražen pri mladostnicah. Skrbza ustrezno rast je ena od prednostnih nalog pri obravnavi otrok in mladostnikov s končno ledvično odpovedjo. Novi brez-steroidni imunosupresivni protokoli, bi lahko izboljšali rast po presaditvi ledvice. Sodobno imunosupresivno zdravljenje je pomembno zmanjšalo število akutnih zavrnitvenih reakcij. Hkrati se je povečalo število virusnih in bakterijskih okužb po presaditvi. Okužbe so najpogosteje navedeni razlogi za smrt otrok s presajeno ledvico. Pri adolescentih in mladih odraslih, ki imajo kronično ledvično bolezen od otroštva, pa predstavljajo glavni zaplet srčno-žilne bolezni</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-WDWZDMYS"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-WDWZDMYS" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-WDWZDMYS/104d789a-df35-43ea-8cbc-710e13626ba6/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-WDWZDMYS/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-WDWZDMYS" /></ore:Aggregation></rdf:RDF>